Esperite N.V. convenes EGM to approve new share option scheme
(Thomson Reuters ONE) -
Esperite N.V. (Euronext: ESP, 'Esperite') announces it is convening an
extraordinary general meeting of Shareholders ("EGM") to be held on Wednesday
23 December 2015 to approve its new share option scheme.
The EGM's convocation notice, agenda and the explanatory notes to the agenda are
available free of charge at Esperite's offices in Zutphen, the Netherlands and
can be downloaded from Esperite's website, www.esperite.com.
About ESPERITE
ESPERITE Group, listed at Euronext Amsterdam and Paris, is a leading
international company in regenerative and predictive medicine established in
2000.
To learn more about ESPERITE Group, or to book an interview with CEO Frederic
Amar: +31 575 548 998 - ir(at)esperite.com or visit the websites at
www.esperite.com and www.genoma.com.
PR EGM 23.12.2015:
http://hugin.info/143308/R/1966224/718032.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Esperite N.V. via GlobeNewswire
[HUG#1966224]
Unternehmensinformation / Kurzprofil:
Datum: 11.11.2015 - 18:40 Uhr
Sprache: Deutsch
News-ID 433869
Anzahl Zeichen: 1537
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 249 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Esperite N.V. convenes EGM to approve new share option scheme"
steht unter der journalistisch-redaktionellen Verantwortung von
Esperite N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
